{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":24,"n_cols":5,"rows_kept":24,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[18,2,18,3],[19,2,19,3],[21,2,21,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910980484703321"]
[null,null,"Autore",null,"Pathak Surajit"]
[null,null,"Titolo",null,"Microbiota and Dietary Mediators in Colon Cancer Prevention and Treatment / / edited by Surajit Pathak, Antara Banerjee, Asim K. Duttaroy"]
[null,null,"Pubbl/distr/stampa",null,"Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024"]
[null,null,"ISBN",null,"9789819602971"]
[{"$nulls":4},"9819602971"]
[null,null,"Edizione",null,"[1st ed. 2024.]"]
[null,null,"Descrizione fisica",null,"1 online resource (473 pages)"]
[null,null,"Disciplina",null,"579"]
[null,null,"Soggetti",null,"Microbiology"]
[{"$nulls":4},"Biology"]
[{"$nulls":4},"Cancer"]
[{"$nulls":4},"Cancer - Prevention"]
[{"$nulls":4},"Cancer - Treatment"]
[{"$nulls":4},"Biological Sciences"]
[{"$nulls":4},"Cancer Biology"]
[{"$nulls":4},"Cancer Prevention"]
[{"$nulls":4},"Cancer Therapy"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"1. Gut microbiota and its Importance in Health and Disease -- 2Recent Innovations in Probiotics and Prebiotics and Gut health -- 3. The Mechanistic Perspectives of Functional Foods - Probiotics and Prebiotics: A Focus on Colon Cancer and Human Health -- 4. Health Benefits of Probiotics and Prebiotics interaction -- 5. Genetically Engineered Probiotics and Potential in Therapeutic Applications -- 6. Probiotic, Prebiotic, and Gut-Brain Connection in Cancer Development -- 7. The influence of prebiotics and probiotics in colorectal cancer treatment -- 8. ROLE OF DIETARY PHYTOCHEMICALS IN GUT DYSBIOSIS: IMPLICATIONS IN COLON CANCER PREVENTION AND TREATMENT -- 9. Probiotics: Immune responses and gut microbiome -- 10. Probiotics Formulation and Cancer Nano-vaccines in GI-Tract Cancer -- 11. Association between Gut Microbiome and Liver and Colon Cancer -- 12. Prebiotic Fortification: Millets in Building Resilience Against Colon Cancer -- 13. Probiotics in Colorectal Cancer: An Emphasis on "]
[{"$nulls":4},"Immunomodulatory and Anti-Cancer Properties -- 14. Cancer Risk in Alterations of Prebiotics -- 15. Priming the Nutrition-Gut-Immuno-Oncology Axis -- 16. Probiotics & Prebiotics in IBS. Therapeutic role of probiotics & prebiotics in irritable bowel syndrome."]
[null,null,null,"Sommario/riassunto","The book discusses the role of gut microbiome composition in colorectal cancer progression, linking intestinal inflammation, tumorigenesis and anti-cancer immune responses. Chapters delve into various areas, including the mechanisms of action of probiotics and prebiotics (such as Lactobacillus and Bifidobacterium strains, and fructans and galactans, respectively), functional foods such as α-carotene, β-carotene, lutein, β-cryptoxanthin, fucoxanthin, isothiocyanates, flavonoids, probiotics, fibre and omega-3. Lycopene, β-cryptoxanthin, and fucoxanthin. Dietary phytochemicals such as polyphenols (curcumin, gingerol, ferulic acid (FA) and hydroxytyrosol); alkaloids (piperine, and protopine); terpenoids (artemisinin, and astaxanthin); iridoid glycoside (picroside II, and morroniside); and flavonoid (quercetin) on cancer, immune responses, and the gut microbiome. It examines the interaction and influence of prebiotics and probiotics in colorectal cancer treatment, their use in managing chemotherapy-related gastrointestinal problems, and their potential as adjuvants. The book also investigates how these gut microbes are associated with tumor progression and anti-cancer treatment efficacy. This knowledge can be used to develop biomarkers that predict immunotherapy effectiveness and improve treatment outcomes through modulation. This book provides a comprehensive update on the latest research and clinical applications in the field, offering valuable insights into the complex interplay between probiotics, the gut microbiome, and colorectal cancer. It serves as an invaluable resource for healthcare professionals, researchers, and students seeking to understand this dynamic area of study."]